Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor
KAPLAN, Nachum, ALBERT, Monique, SCHMID, Molly B, THALAKADA, Rosanne, YETHON, Jeremy, PAULS, Henry W, AWREY, Donald, BARDOUNIOTIS, Elias, BERMAN, Judd, CLARKE, Teresa, DORSEY, Mandy, HAFKIN, Barry, RAMNAUTH, Jaillal, ROMANOV, Vladimir
Published in Antimicrobial Agents and Chemotherapy (01.11.2012)
Published in Antimicrobial Agents and Chemotherapy (01.11.2012)
Get full text
Journal Article
Hematologic Effects of Linezolid: Summary of Clinical Experience
GERSON, Stanton L, KAPLAN, Sheldon L, BRUSS, Jon B, LE, Vu, ARELLANO, Felix M, HAFKIN, Barry, KUTER, David J
Published in Antimicrobial Agents and Chemotherapy (01.08.2002)
Published in Antimicrobial Agents and Chemotherapy (01.08.2002)
Get full text
Journal Article
Worldwide Assessment of Linezolid's Clinical Safety and Tolerability: Comparator-Controlled Phase III Studies
Rubinstein, Ethan, Isturiz, Raul, Standiford, Harold C, Smith, Leon G, Oliphant, Thomas H, Cammarata, Sue, Hafkin, Barry, Le, Vu, Remington, Jack
Published in Antimicrobial Agents and Chemotherapy (01.06.2003)
Published in Antimicrobial Agents and Chemotherapy (01.06.2003)
Get full text
Journal Article
Randomized Comparison of Linezolid (PNU-100766) versus Oxacillin-Dicloxacillin for Treatment of Complicated Skin and Soft Tissue Infections
Stevens, D L, Smith, L G, Bruss, J B, McConnell-Martin, M A, Duvall, S E, Todd, W M, Hafkin, B
Published in Antimicrobial Agents and Chemotherapy (01.12.2000)
Published in Antimicrobial Agents and Chemotherapy (01.12.2000)
Get full text
Journal Article
In Vitro and In Vivo Activities of Contezolid (MRX-I) against Mycobacterium tuberculosis
Shoen, Carolyn, DeStefano, Michelle, Hafkin, Barry, Cynamon, Michael
Published in Antimicrobial agents and chemotherapy (01.08.2018)
Published in Antimicrobial agents and chemotherapy (01.08.2018)
Get full text
Journal Article
Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosis
Almeida, Deepak, Li, Si-Yang, Lee, Jin, Hafkin, Barry, Mdluli, Khisimuzi, Fotouhi, Nader, Nuermberger, Eric L
Published in Antimicrobial agents and chemotherapy (14.12.2023)
Published in Antimicrobial agents and chemotherapy (14.12.2023)
Get full text
Journal Article
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens
Bulitta, Jürgen B, Fang, Edward, Stryjewski, Martin E, Wang, Wen, Atiee, George J, Stark, Jeffrey G, Hafkin, Barry
Published in Antimicrobial agents and chemotherapy (03.04.2024)
Published in Antimicrobial agents and chemotherapy (03.04.2024)
Get full text
Journal Article
In vitro activity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics
Kaplan, Nachum, Awrey, Donald, Bardouniotis, Elias, Berman, Judd, Yethon, Jeremy, Pauls, Henry W, Hafkin, Barry
Published in Journal of chemotherapy (Florence) (01.02.2013)
Published in Journal of chemotherapy (Florence) (01.02.2013)
Get full text
Journal Article
Single-Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a FabI Inhibitor, the Prodrug Debio 1450 and Its Active Moiety Debio 1452, Administered Intravenously in Healthy Subjects
Hafkin, Barry, Berg, Jolene K, Kaplan, Nachum, Métral, Valérie Nicolas, Ménétrey, Annick, Alcorn, Harry, Wittke, Frederick
Published in Open forum infectious diseases (09.12.2015)
Published in Open forum infectious diseases (09.12.2015)
Get full text
Journal Article
In vitro activity (MICs and rate of kill) of AFN-1252, a novel Fabl inhibitor, in the presence of serum and in combination with other antibiotics
KAPLAN, Nachum, AWREY, Donald, BARDOUNIOTIS, Elias, BERMAN, Judd, YETHON, Jeremy, PAULS, Henry W, HAFKIN, Barry
Published in Journal of chemotherapy (Florence) (2013)
Get full text
Published in Journal of chemotherapy (Florence) (2013)
Journal Article
797Single-Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a FabI Inhibitor, the Prodrug Debio 1450 and Its Active Moiety Debio 1452, Administered Intravenously in Healthy Subjects
Hafkin, Barry, Berg, Jolene K, Kaplan, Nachum, Métral, Valérie Nicolas, Ménétrey, Annick, Jr, Harry Alcorn, Wittke, Frederick
Published in Open forum infectious diseases (01.12.2015)
Published in Open forum infectious diseases (01.12.2015)
Get full text
Journal Article